Clinical Trial: ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Pilot, Open, Monocenter Randomized Two Parallel Groups, Clinical Efficacy Trial: Comparison Continuous Versus on Demand Regimen of Treatment With Levocetirizine 5 mg Oral Tablets, Once a Day, in Adu
Brief Summary: Comparison of clinical efficacy and safety of levocetirizine in PER continuous versus on demand, measured by evolution of individual symptom scores during 6 months.
Detailed Summary:
Sponsor: UCB Pharma
Current Primary Outcome: Evolution of the mean weekly T4SS (sum of the individual symptoms scores) during 6 months of treatment
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Evolution of inflammatory cells concentrations and expression of ICAM-1 in nasal scrapings at baseline/after 1, 3 and 6 months of treatment Evolution of Rhinasthma scores, weekly/monthly number of days with (acute) rhinitis symptoms
- Intake of concomitant/rescue medication
- Safety
Original Secondary Outcome: Same as current
Information By: UCB Pharma
Dates:
Date Received: September 8, 2005
Date Started: March 2005
Date Completion:
Last Updated: December 13, 2013
Last Verified: September 2009
